Overview

Intravenous Clarithromycin in Septic Syndrome

Status:
Completed

Trial end date:
2005-12-01

Target enrollment:

Participant gender:

Summary

The aim of this clinical trial is to clarify the clinical efficacy of clarithromycin as immunotherapy for the management of septic syndrome by ventilator-associated pneumonia.

Phase:

Phase 4

Details

Lead Sponsor:

University of Athens

Treatments:

Clarithromycin